Gene Watch
Council for Responsible Genetics, May 2013
GeneWatch is America's first and only magazine dedicated to monitoring biotechnology's social, ethical and environmental consequences. Since 1983, GeneWatch has covered a broad spectrum of issues, from genetically engineered foods to biological weapons, genetic privacy and discrimination, reproductive technologies, and human cloning.
While the field of biotechnology holds the potential for dramatic progress in the future, it is also full of misinformation and exaggerated claims. Indeed, biotechnology presents profound national and global policy concerns as well; including the potential impact of scientific developments on human rights and public health. Now, more than ever, there is the need for a strong, independent watchdog.
Countries covered include: the United Kingdom, Canada, countries within the EU, Australia & India.
This GeneWatch subscription provides 5 to 6 magazines annually.
Volume 24 Issue 1: Biobanks; Feb-Mar 2011
Time to Raise Some Hell By Henry T. Greely
Suspect Creatures By CRG staff - with George Annas, Robert Green, Patricia Roche and Susan Wolf
The Harm of Hype By CRG staff - interview with James Evans
UK Biobank: The Grand Experiment By Helen Wallace
From the Cradle to the Lab By Samuel W. Anderson
Book Review: Ethical Issues of Human Genetic Databases By Andrew D. Thibedeau
Case in Point: The NIH’s Biobank Breach By CRG Staff
Genetic Privacy Worries on the Rise By CRG staff - interview with Christy White, Cogent Research
Re-lighting the Beacon By Steve May
GM Alfalfa: An Uncalculated Risk By Philip Bereano
Topic Update: Direct-to-Consumer Genetic Testing Criticized at FDA Hearing By CRG Staff
Editorial By Samuel W. Anderson
Since 1983, the Council for Responsible Genetics (CRG) has represented the public interest and fostered public debate about the social, ethical and environmental implications of genetic technologies. It is the only biotech public interest organization that is explicitly dedicated to examining the best science, interpreting the results, assessing the implications, communicating them to a general audience and facilitating meaningful, measurable change.
CRG continues to carry out these functions through the creation of coalitions of scholars and advocates; translation of scientific and policy analyses into clear and accessible terms for the public, social justice advocates, legislators and the media; and by providing an international, science based source of credible, trusted, current and reliable information on the impacts and implications of developments in biotechnology. Its staff and Board members regularly assist policy makers and have testified before Congress, Federal agencies, regulatory bodies and state legislatures.
The Council for Responsible Genetics is a leader in the movement to steer biotechnology toward the advancement of public health, environmental protection, equal justice, and respect for human rights through lasting policy reform in the United States and around the world.
- GlaxoSmithKline
- 23andMe
- Navigenics
- Myriad Genetics
- Monsanto
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
